Although controversial, recent studies suggest that serous ovarian carcinomas may arise from fallopian tube fimbria rather than ovarian surface epithelium. We developed an in vitro model for serous carcinogenesis in which primary human fallopian tube epithelial cells (FTECs) were exposed to potentially oncogenic molecular alterations delivered by retroviral vectors. To more closely mirror in vivo conditions, transformation of FTECs was driven by the positive selection of growth-promoting alterations rather antibiotic selection. Injection of the transformed FTEC lines in SCID mice resulted in xenografts with histologic and immunohistochemical features indistinguishable from poorly differentiated serous carcinomas. Transcriptional profiling r...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
Beginning with the discovery of the BRCA-associated ovarian cancer susceptibility genes and subseque...
AbstractAlthough controversial, recent studies suggest that serous ovarian carcinomas may arise from...
AbstractAlthough controversial, recent studies suggest that serous ovarian carcinomas may arise from...
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
Ovarian cancer is the sixth most lethal cancer in women. Out of all ovarian cancers – the high grade...
Ovarian cancer is the sixth most lethal cancer in women. Out of all ovarian cancers – the high grade...
High-grade serous cancer (HGSC) progresses to advanced stages without symptoms and the 5-year surviv...
Recent evidence suggests that ovarian high-grade serous carcinoma (HGSC) originates from the epithel...
High grade serous ovarian cancer (HGSC), the most lethal and frequent type of epithelial ovarian can...
The fallopian tube epithelium (FTE) has been recognized as a site of origin of high-grade serous ova...
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
The fallopian tube epithelium (FTE) has been recognized as a site of origin of high-grade serous ova...
Germline or somatic mutation(s) in BRCA1 is associated with a 40-50% lifetime risk of developing hig...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
Beginning with the discovery of the BRCA-associated ovarian cancer susceptibility genes and subseque...
AbstractAlthough controversial, recent studies suggest that serous ovarian carcinomas may arise from...
AbstractAlthough controversial, recent studies suggest that serous ovarian carcinomas may arise from...
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
Ovarian cancer is the sixth most lethal cancer in women. Out of all ovarian cancers – the high grade...
Ovarian cancer is the sixth most lethal cancer in women. Out of all ovarian cancers – the high grade...
High-grade serous cancer (HGSC) progresses to advanced stages without symptoms and the 5-year surviv...
Recent evidence suggests that ovarian high-grade serous carcinoma (HGSC) originates from the epithel...
High grade serous ovarian cancer (HGSC), the most lethal and frequent type of epithelial ovarian can...
The fallopian tube epithelium (FTE) has been recognized as a site of origin of high-grade serous ova...
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
The fallopian tube epithelium (FTE) has been recognized as a site of origin of high-grade serous ova...
Germline or somatic mutation(s) in BRCA1 is associated with a 40-50% lifetime risk of developing hig...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
Beginning with the discovery of the BRCA-associated ovarian cancer susceptibility genes and subseque...